IL37 and atherosclerosis: However, genetic ablation of IL-23 or IL-23R in hematopoietic cells unexpectedly accelerates atherosclerosis development, particularly due to the loss of downstream IL-22 expression and IL-22-dependent intestinal homeostasis and host–microbiota détente [71].